<DOC>
	<DOCNO>NCT01457664</DOCNO>
	<brief_summary>This study evaluate safety , tolerability pharmacokinetics RO4995819 healthy elderly volunteer . Volunteers randomize receive daily dos RO4995819 match placebo . The anticipated time study treatment 14 day .</brief_summary>
	<brief_title>A Study RO4995819 Healthy Elderly Volunteers</brief_title>
	<detailed_description />
	<criteria>Adult healthy volunteer , 6585 year age Body Mass Index ( BMI ) 18.0 30.0 kg/m2 inclusive total body weight &gt; 50 kg ( 110 lb ) Able participate willing give write informed consent comply study restriction Any history suspicion drug alcohol abuse Clinically significant unstable cardiovascular bronchopulmonary disease , type cancer History liver disease Significant past present neurological disorder History psychiatric disorder Participation investigational drug device study within 12 week prior screen Donation blood 500 mL within three month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>